Ticker
$TARO
Industry
Pharma
Type
Beaten Up
Rating
Covered
Category
General
Target Price
$53.00
Latest Report
Price performance has been terrible with virtually no returns for a decade+
Notes
- Controlled (78.5% ownership) by Sun Pharma — an India-based drug company; attempted several takeovers at low prices in years’ past
- US generics company (mostly dermatology products) with huge net cash position
- 2018 sales fell off from generic competition and patent losses
‣
‣
Resources
‣
‣
‣
‣